Therapeutic cancer vaccines: a long and winding road to successBAXEVANIS, Constantin N; PAPAMICHAIL, Michael; PEREZ, Sonia A et al.Expert review of vaccines. 2014, Vol 13, Num 1, pp 131-144, issn 1476-0584, 14 p.Article

Characterization of a novel cell penetrating peptide derived from Bag-1 proteinNIARCHOS, Dimitrios K; PEREZ, Sonia A; PAPAMICHAIL, Michael et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 11, pp 2661-2669, issn 0196-9781, 9 p.Article

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RIMAMALAKI, Avgi; GRITZAPIS, Angelos D; KRETSOVALI, Androniki et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 8, pp 513-522, issn 0340-7004, 10 p.Article

Natural CD8⁺ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumorsSOTIROPOULOU, Panagiota A; PEREZ, Sonia A; VOELTER, Volfgang et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 12, pp 771-779, issn 0340-7004, 9 p.Article

Increased frequency of CD4⁺ cells expressing CD161 in cancer patientsILIOPOULOU, Eleni G; KARAMOUZIS, Michalis V; MISSITZIS, Ioannis et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 6901-6909, issn 1078-0432, 9 p.Article

HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4⁺T cell clonesPEREZ, Sonia A; SOTIROPOULOU, Panagiota A; SOTIRIADOU, Nectaria N et al.Cancer immunology and immunotherapy. 2002, Vol 50, Num 11, pp 615-624, issn 0340-7004Article

HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor propertiesGRITZAPIS, Angelos D; FRIDMAN, Arthur; PEREZ, Sonia A et al.Vaccine. 2010, Vol 28, Num 1, pp 162-170, issn 0264-410X, 9 p.Article

A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survivalPEREZ, Sonia A; MAHAIRA, Louisa G; DEMIRTZOGLOU, Fillio J et al.Blood. 2005, Vol 106, Num 1, pp 158-166, issn 0006-4971, 9 p.Article

A novel myeloid-like NK cell progenitor in human umbilical cord bloodPEREZ, Sonia A; SOTIROPOULOU, Panagiota A; GKIKA, Dimitra G et al.Blood. 2003, Vol 101, Num 9, pp 3444-3450, issn 0006-4971, 7 p.Article

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapyLEKKA, Eftychia; GRITZAPIS, Angelos D; PEREZ, Sonia A et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 5, pp 715-727, issn 0340-7004, 13 p.Article

Results from a Phase I Clinical Study of the Novel Li-Key/HER-2/neu(776-790) Hybrid Peptide Vaccine in Patients with Prostate CancerPEREZ, Sonia A; KATLLINTERIS, Nikoletta L; BISIAS, Stratos et al.Clinical cancer research (Print). 2010, Vol 16, Num 13, pp 3495-3506, issn 1078-0432, 12 p.Article

Mannose addition by yeast Pichia Pastoris on recombinant HER-2 protein inhibits recognition by the monoclonal antibody herceptinVLAHOPOULOS, Spiros; GRITZAPIS, Angelo D; PEREZ, Sonia A et al.Vaccine. 2009, Vol 27, Num 34, pp 4704-4708, issn 0264-410X, 5 p.Article

CD4⁺CD25⁺ regulatory T-cell frequency in HER-2/neu (HER)-positive and her-negative advanced-stage breast cancer patientsPEREZ, Sonia A; KARAMOUZIS, Michael V; PAPAMICHAIL, Michael et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2714-2721, issn 1078-0432, 8 p.Article